Also trades as: LOBE.CN (CNQ) · $vol 0M
LOBEF OTC
Lobe Sciences Ltd.
1W: -20.3%
1M: -35.6%
3M: -45.2%
YTD: +10.4%
1Y: +9.5%
3Y: +106.0%
$0.04
+0.00 (+3.38%)
Weekly Expected Move ±15.0%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$4M
-97.4% ▼
Net Income
-$4M
-0.1% ▼
EPS (Diluted)
$-0.03
+11.9% ▲
EBITDA
-$4M
-3.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $841K | $136K | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | -83.8% | -100.0% |
| Cost of Revenue | $0 | $0 | $24K | $2K | $0 |
| Gross Profit | $0 | -$10K | $817K | $134K | $0 |
| Gross Margin | — | — | 97.1% | 98.7% | — |
| R&D Expenses | $1M | $418K | $1M | $386K | $641K |
| SG&A Expenses | $5M | $4M | $3M | $2M | $4M |
| Operating Expenses | $6M | $4M | $4M | $2M | $4M |
| Operating Income | -$6M | -$4M | -$3M | -$2M | -$4M |
| Operating Margin | — | — | -399.6% | -1553.5% | — |
| Interest Expense | $0 | $0 | $39K | $187K | $596K |
| Income Before Tax | -$24M | -$12M | -$5M | -$4M | -$5M |
| Tax Expense | -$1M | $0 | $205K | $33K | $0 |
| Net Income | -$10M | -$12M | -$5M | -$4M | -$4M |
| Net Margin | — | — | -560.0% | -3245.8% | — |
| EPS (Diluted) | $-0.30 | $-0.32 | $-0.05 | $-0.04 | $-0.03 |
| EBITDA | -$6M | -$4M | -$4M | -$4M | -$4M |
| Shares Outstanding | 32M | 38M | 104M | 122M | 139M |